Z-215 20mg

DRUG2 trials

Sponsors

Zeria Pharmaceutical

Conditions

Esophagitis, RefluxHealthy

Phase 1

To Evaluate Pharmacokinetics and Pharmacodynamics of Z-215 in Healthy Male Subjects

CompletedNCT02509923

Zeria PharmaceuticalHealthy

Start: 2015-07-31End: 2016-09-30Updated: 2016-09-22

Phase 2

To Evaluate Efficacy and Safety of Z-215 in Erosive Esophagitis

CompletedNCT02463643

Zeria PharmaceuticalEsophagitis, Reflux

Start: 2015-05-31End: 2017-03-31Updated: 2017-07-02